Recombinant human erythropoietin for the treatment of refractory anemia in lymphoproliferative disorders: preliminary results.
Tsiara
S t
St
Kaiafas
P
P
Kapsali
E
E
Christou
L
L
Bourantas
K L
KL
D000368:Aged; D000753:Anemia, Refractory / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications; D008232:Lymphoproliferative Disorders / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D008258:Waldenstrom Macroglobulinemia / Q000150:complications
D011994:Recombinant Proteins; D004921:Erythropoietin